A study finds that a significant number of FDA-mandated studies are unfinished.
Medical cannabis classes will no longer be held at the University of Maryland-Baltimore.
A pharmacy organization says all health-providers need to help prevent and fight antimicrobial resistance.
FDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
A new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.
New data show that health benefit costs in 2018 will rise by their highest since 2011.
Gottlieb says that changes may be coming, but remains firm on current regulations.
Opioid limits are gaining popularity, but do they actually work?
Check out the latest changes to the Express Scripts formulary
Neratinib (Nerlynx) is an extended adjuvant treatment for patients with early stage HER2 positive breast cancer who are receiving trastuzumab therapy.